NADPH (tetracyclohexanamine)

CAS No. 100929-71-3

NADPH (tetracyclohexanamine)( —— )

Catalog No. M22481 CAS No. 100929-71-3

NADPH (tetracyclohexanamine) is a cofactor and biological reducing agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 In Stock
25MG 73 In Stock
50MG 120 In Stock
100MG 183 In Stock
200MG 272 In Stock
500MG 461 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NADPH (tetracyclohexanamine)
  • Note
    Research use only, not for human use.
  • Brief Description
    NADPH (tetracyclohexanamine) is a cofactor and biological reducing agent.
  • Description
    NADPH (tetracyclohexanamine) is a cofactor and biological reducing agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Ferroptosis
  • Recptor
    Ferroptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100929-71-3
  • Formula Weight
    1142.12
  • Molecular Formula
    C45H82N11O17P3
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:100 mg/mL (87.56 mM);DMSO:84 mg/mL (73.55 mM)
  • SMILES
    NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Erastin2

    Erastin2 is a ferroptosis inducer and inhibitor of the system xc- cystine/glutamate transporter.

  • Erastin

    Erastin is a ferroptosis activator by acting on mitochondrial VDAC, exhibiting selectivity for tumor cells bearing oncogenic RAS.

  • UAMC-3203

    UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM.